|
Medica III |
|
Dynamix Pharmaceuticals Ltd.
Proprietary DynamixFit TM technology for metabolic disorder, inflammatory disease, and cancer drug discovery.
|
|
 |
PainReform
Reformulated products to enhance efficacy, reduce adverse effects and increase convenience for the treatment of pain.
www.painreform.com |
|
 |
Sol-Gel Technologies (SGT)
Innovative drug delivery solutions for the pharmaceutical and skincare industries, using proprietary technology for microencapsulation in silica.
www.sol-gel.com |
|
NYSE: MDT |
Ventor Technologies
Unique aortic valve prosthesis designed for easy, minimally invasive implantation, improved anchoring and superior hemodynamic performance.
Acquired by Medtronic in February 2009. |
|
 |
Regentis
Gelrin TM device for cartilage and other tissue repair.
www.regentis.co.il |
|
 |
Endymion
Next generation medical aesthetic devices for skin rejuvenation, wrinkle reduction and skin tightening; Proprietary
OnePulse TM and 3Deep TM
technologies, provide multilayer, targeted & controlled desired clinical effects.
Batsheva Elran, belran@medicavp.com |
|
 |
Gardia Medical
Specialized catheter-based delivery systems for interventional cardiovascular procedures; Deliver, Lock, and Deploy devices anywhere on any guidewire.
www.gardiamedical.com |
|
 |
Expanding Orthopedics (EOI)
Novel, proprietary, solutions for Spinal Stabilization and Long Bone Fracture Fixation. Product solutions address both previously unsolved
surgical problems and underserved markets.
www.exortho.com |
|
 |
GlobeImmune
Tarmogen TM therapy to mobilize the immune system for the treatment of cancer and infectious disease.
www.globeimmune.com |
|
NYSE: BSX |
Remon Medical Technologies
Cutting edge telemetric technology enables implantable devices to communicate wirelessly with external system, providing physicians with valuable tools
to frequently monitor and treat several potential life threatening conditions. Acquired by Boston Scientific Corporation in June 2007.
www.remonmedical.com |
|
|
Medica I & II
|
 |
Lumenis
Global leader in medical and aesthetic lasers and light-based technology for treatment of medical and cosmetic conditions.
www.lumenis.com |
|
NASDAQ: ABMD |
Impella
Integrated cardiac assist blood pump for interventional cardiology and cardiac surgery. Acquired by
ABiomed in April 2005.
www.abiomed.com |
|
 |
SuperDimension
3D navigation systems (CT-guided bronchoscopy) for minimally-invasive diagnosis and treatment of lung
disease.
www.superdimension.com
|
|
NASDAQ: ANGO |
FlowMedica
Minimally invasive intravascular systems for targeted renal therapy.
Acquired by AngioDynamics in January 2009.
www.flowmedica.com |
|
TASE: INCR |
InterCure
Breakthrough medical devices for non-invasive treatment of cardiovascular and pulmonary diseases. IPO:TASE:INCR, July 2007.
www.intercure.com |
|
 |
Collgard Biopharmaceuticals
Tempostatin TM - novel therapy for cancer, restenosis & fibrosis.
www.collgard.com |
|
NYSE: EK |
Orex Computed Radiography Ltd.
Desktop computed radiography: no films, no chemicals, PC based. Acquired by Kodak in March 2005.
www.orex-cr.com |
|
NASDAQCM: AMRND |
Ester Neurosciences
New drugs providing a paradigm shift in treatment of neurological disorders. Acquired by Amarin Corporation in December 2007.
www.amarincorp.com |
|
NYSE: EW |
Percutaneous Valve Technologies
Revolutionary products for minimally-invasive replacement of heart valves. Acquired by Edwards Life
Sciences in February 2004.
www.edwards.com |
|
NASDAQ: MEMY
VTX: ROG
|
Memory
Developing innovative drugs for the treatment of debilitating central nervous system (CNS) disorders.
IPO: NASDAQ: MEMY, April 2004. Acquired by Roche in December 2008.
www.memorypharma.com |
|
NASDAQNM: XTLB
LSE: XTL |
XTL Biopharmaceuticals, Ltd.
Human therapeutic antibodies, and small molecules for Hepatitis B and C & related liver transplants.
IPO:LSE: XTL, 2000. NASDAQ: XTLB.
www.xtlbio.com |
|
NYSE: JNJ
AMEX: IMA |
Selfcare
Diagnostics products for chronic diseases: World leader in blood glucose monitoring for diabetes.
Acquired by J&J.
|
|
NEOP.OB |
Neoprobe
Technology for disease targeting agents and gamma detecting medical devices designed to provide surgeons
with the location of hidden cancer during surgery. Company was subsidiary of NASDAQ: NEOP.OB.
www.neoprobe.com
|
